Healthywelth, my point with the 4yr old article was that Dr.Damaj had a failed product (zyoptic) that he had to remove, so what's to prevent that from happening to other products. (Duh!, can't you read between the lines healthywelth, just how dense are you, geez!??)
Also, more importantly in the article he wanted to be profitable and uplist to the NASDAQ 3 years ago!
Dr.Damaj expected to be profitable 3 years ago!
Dr.Damaj expected Fluticare to be approved way back in 2015!
Dr.Damaj is a bad judge of timing and profitability!
News 
Market Data 
Discover 
AI
